Maciejek Z et al. |
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report. |
|
Neurol. Neurochir. Pol. |
pmid:23650003
|
Li XK et al. |
FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecular ICAM-1 in TNF-alpha treated human umbilical vein endothelial cells. |
|
Transplant. Proc. |
pmid:9123298
|
Pruvost R and Le Stunff H |
[Sphingosine kinase-1: role in non alcoholic fatty liver disease]. |
|
Med Sci (Paris) |
pmid:27615179
|
Francois M et al. |
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis. |
|
Pharm Stat |
pmid:22888087
|
Kahan BD |
FTY720: a new dimension in transplantation. |
|
Transplant. Proc. |
pmid:11750324
|
Brinkmann V et al. |
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. |
|
Transplant. Proc. |
pmid:11750323
|
Kelly-Laubscher RF et al. |
Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. |
|
Cardiovasc J Afr |
pmid:25000441
|
Chen S et al. |
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines. |
|
Transplant. Proc. |
pmid:11750317
|
Tabasinezhad M et al. |
Sphingosin 1-phosphate contributes in tumor progression. |
|
J Cancer Res Ther |
pmid:24518696
|
Duan RD |
Anticancer compounds and sphingolipid metabolism in the colon. |
|
In Vivo |
pmid:15796189
|